Guidant Ancure Endograft System

There are at least 18,000 patients who received Ancure Endograft System devices, a product manufactured by Endovascular Technologies, Inc., a subsidiary of Guidant Corporation. This device was used to repair abdominal aortic aneurysms, by reinforcing a bulge or weakness in the wall of the aorta, the large blood vessel carrying blood from the heart to the rest of the body. This device consisted of a flexible fabric that was inserted into the aorta by a catheter and then attached with metal hooks. The FDA found that the manufacturer's sales representatives, who were present during the operations, were encouraging doctors to use unapproved techniques for insertion of the device. Also, there are concerns about whether the manufacturer was overly aggressive in marketing the device by ignoring its own guidelines and approving patients for whom the device was inappropriate. Recently, Guidant pled guilty to ten felonies and agreed to pay $92.4 million in penalties for various violations of federal law in connection with this product and failure to report 2,600 adverse events relating to the Ancure Endograft System product.

If you or a loved one are experiencing any of these symptoms or are having serious health problems as a result of a drug-coated heart stent, please contact Alley, Clark & Greiwe to learn more about your legal rights.